The expression pattern of these genes is consistent with the metabolic memory phenotype and demonstrates that even a one month period of loss of insulin signalling and hyperglycemia can result in molecular alterations that are unresponsive to insulin treatment. This evidence concerns the gene INS and Hyperglycemia.